cost

Costco Wholesale Corp

market

A stock prices ten years ahead is everything that is wrong with the market.

$COST Market don’t work with our feelings or emotional opinion 🤣

$COST F*** this Rigged Corrupted market !!! !

$COST Damn right, think opposite of what the Market is telling you

$COST lol the market has been down all week and this morning.

$COST Look at boxd way below market value.

$COST that jobs report killed
Our momentum today

Remember it’s a shills job to talk you into making bad decisions

$COST Fed did a poor job to destroy the demand.

target

$COST CVS, Walgreens, Target increasing in theft, empty shelves, locked products, longer customer wait times.

😭

All I can say is that the prices in Target have gone from high to. nuts.

$COST Ha, ridiculous $3 price target drop.

$COST man out of all retail this garbage has a hangman on it on the daily fuck me lmao I couldnt figure out why I was losing money all day and why Target and walmart were green and not selling off like costco now I see why wow what a damn miss damn

$TGT $SPY $COST 

I think it is possible the retail theft problem is as bad as Target claims.

recession

$COST if they raise their membership prices im out that’s stupid especially in a recession I’m with you

$COST raising membership prices going into recession not good idea

$COST yeah, people wont go here in a recession after paying their membership fee, nope, lol

report

$COST they better report AWESOME December sales , i seen enough of this dropping shit, lol

$COST hmmm maybe this is not good 
US manufacturing orders in China drop 40% amid COVID-19 lockdowns: report.

$COST  The bullish trend in the options market suggests a positive outlook for the stock We are seeing the $450 CALL having heavy activity which expire in 38 days.

$COST 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣

$COST nice wedge here 🫡🔒 all I gottta say 🤫

$COST 2hr looking bullish, she wanna touch the 200 day which is 296, juicy

$COST The chart points towards an optimistic outlook for the stock.

$COST Always a buy in the 470s, congratulations to those who got it this a.m.

FTCH #farfetch is blazing, technologic curated access to  3,400 brands from 1,400 luxury sellers, including 820 leading luxury retailers &amp; 590 brands, full of virtuoso middle-manning, terrific momentum, &amp; a compelling story.

$COST decent buying opp sub $480 (nfa) -- GLTA &gt; long &amp; accumulating

Costco shares jumped 7.3%, the biggest gainer on the Nasdaq and the second-best on the S&amp;P 500.

🗣BofA on $COST

“well-positioned long-term given: 1) Share gains given COST’s strong value proposition &amp; price positioning, 2) potential store acceleration given excess demand, 3) competitive advantages afforded by unique sourcing model….”

I will add more with bad ER, and keep going back for more gas &amp; glizzy’s.

COST has inverted H&amp;N. A lot analysts (very obvious on CNBC half time report yesterday) still love this stock.

This is amongst the best returns in the industry. https://www.chartmill.com/stock/quote/COST/fundamental-analysis?key=6e7648dc-edbb-41fb-afb1-10eb2543fbdb&amp;utm_source=stocktwits&amp;utm_medium=FA&amp;utm_content=COST&amp;utm_campaign=social_tracking

company

This will be a trillion dollar company one day

Its a subscription company better than Netflix with 93% renewal rate and still expanding to new countries and increasing membership price.

$SDC how I love this company at these levels.

$HD $COST $MCD some great companies on this list of 20! https://www.fool.com/investing/2023/01/04/20-recession-proof-stocks-to-buy-now-for-2023/

Probably one of the most popular companies in the USA!

We alerted the BUY signal at $481.54 and we were able to close this one with profit at $485.58 💯

We alerted the BUY signal at $475.45 and we were able to close this one with profit at $482.1 💖

We alerted the BUY signal at $483.03 and we were able to close this one with profit at $486.18 💖

That makes it a good buy at current prices.

$COST Buy now, its cheap in relation to the risk you take.

@RonsRun614 

$GS  $AAPL $JPM  $COST  $SPY 

GREAT GAINS TODAY!

$EVFM $COST great news today for these two 📰 💰🧬

$XBI $SPY $LABU

$SPY $TSLA $QQQ $COST $LULU

Like and follow for more!

$SPY This earnings from $COST to me is good considering all the headwinds around supply chains and economy,

$SPY Costco will beat today after hour 
$COST

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

$SAVA I’m so excited because my cost is average for my shares is $25.87 that’s why hahahahaha you have to be a Short and I’m semi retired hahahaha

$SAVA Mike cost this morning was $31.68 
This morning not too bad

$CDTX FDA decision will be made tomorrow $SAVA, $MDGL &amp; $RETA boys I can easily see this up 200%-300% in my opinion on an approval.

$BIVI what a difference it can make to have a strong ceo: 
Cuong Do (president &amp; ceo): 
Former President of Samsung Global Strategy Group and former Chief Strategy Officer for Merck 
- 
expect the coming 14 days to be really exciting !!

$SAVA 💰Come to papa💰 counterfeiters &amp; Fud will be exposed 🔥🩳🔥

$SAVA to the moon &amp; golden retrievers best in class❤️

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

TG Therapeutics Inc

trading

Unbelievable how negative this stock trades against bio stocks with not much going on besides mediocre trials.

Big Loser Alert: Trading today&#39;s -7.2% move in TG THERAPEUTICS $TGTX https://wp.me/p5bLGB-iva5

↳ Why are you paying to be in a Trading Room?

$TGTX stock action negative this whole week.

$TGTX we&#39;re missing something here, the price action is a bit worrisome.

This price action is pathetic after holding this bag for years.

life

manipulation

It&#39;s eye opening to see the blatant manipulation.

$TGTX no real sellers here, all fake manipulation

Screw off $GS   hope they get crushed from the sec for stock manipulation  I can’t stand these fools.

Practically the only thing red today… lame 😒

$TGTX $19.00 in the red 😎 this thing sends chills down my arms.

It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.

The analyst comments &quot;TGTX stock is up &gt;15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

Each treatment cost under $10k per treatment.

SAFEST &amp; CHEAPEST MS DRUG ON THE PLANET .

beyond TG doing well, and us all making a ton of profit, i genuinely hope that this is the answer a lot of MS patients need to help them navigate &amp; improve their illness.

hold

$TGTX Worthwhile hold and in time will be quite profitable.

$TGTX Please hold your shares or buy more on the dip You will be very pleased with the outcome

$TGTX good day Bulls, just hold for the gold!! !

This will be huge, and the sp for BO will be massive in 2yrs if they hold out. 100+

Buy, Accumulate, Hold…it’s common sense.

$TGTX &gt; STRONG BUY = BUY/HOLD/ACCUMULATE.

Chartwise,  i  would think  this  is   pretty bullish;  given  crap  market. Thoughts?

$TGTX This is the rocky Biden market u all wanted.

Remember that we are ultimately at the beginning of commercialization and quite possible the safest spot to be with the current facts on our superior Briumvi treatment and best pricing for market share penetration.

$TGTX market is doing good, we doing good

$TGTX Looking strong today despite the market.

TG&#39;s Briumvi is positioned to take market share because of these advantages, including how much better it is than all other competitors.

$TGTX  
I found this on NewsBreak: The stock market is on the verge of a rare bullish trifecta that suggests big upside ahead  
https://share.newsbreak.com/2tuqqt3a

I have done plenty of research lately on the market TAM and this looks primed to move quickly once it gets rolling.

$TGTX Up 23% from the lows of pre market 3 trading days ago.

Top Stocks matching your search for "cost amp"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.